Journal article
Can incomplete metastasectomy impact renal cell carcinoma outcomes? A propensity score matching analysis from a prospective multicenter collaboration
Abstract
Objective: To evaluate the role of incomplete metastasectomy (IM) for patients with metastatic renal cell carcinoma (mRCC) on overall survival (OS) and time to introduction of first-line systemic therapy. Methodology: Patients diagnosed with mRCC between Jan 2011 and Apr 2019 in 16 centers were selected from the Canadian Kidney Cancer information system database. We included mRCC patients who had prior nephrectomy and had received an IM …
Authors
Dragomir A; Hesswani C; Marcq G; So AI; Kollmannsberger C; Basappa N; Fairey A; Kapoor A; Lalani A-K; Finelli A
Journal
Société Internationale d’Urologie Journal, Vol. 2, No. 2, pp. 82–95
Publisher
MDPI
DOI
10.48083/wqfr3235
ISSN
2563-6499